• About Us
  • Product Discovery
    • Blood Grouping Reagents
      • ABO, D, AHG AND BOVINE ALBUMIN
      • Lectins
      • Rhesus
      • Others
    • Syphilis
      • Total Antibody Kit
      • VDRL Carbon Antigen
      • RPR – Rapid Plasma Reagin
      • TPHA
      • Rapid Test
    • Febrile Antigens
    • Latex Kits
      • Pregnancy
      • Latex Microbiology
      • Latex Serology
    • Rapid Tests RDTs
  • News and Events
  • Contact Us
28/04/22Posted in Board, Novacyt Group, Products, Uncategorized

Full year 2021 results and update on growth strategy

Full year revenue and EBITDA in line with market expectations despite challenging and changing COVID-19 testing market
Leveraging core capabilities to become a leading, global clinical diagnostics company targeting annual revenues in excess of £100m in five years

http://novacyt.com/wp-content/uploads/2022/04/Novacyt-Full-year-2021-results-and-update-on-growth-strategy.pdf

© 2023 Biotec | Biotec is part of the Novacyt Group of Companies
  • Privacy
  • Copyright
  • Terms and Conditions
  • Careers